We examine five managed healthcare stocks (companies) to assess whether they have recovered from recent industry challenges or remain “sick”.

Initially, stocks rallied on the expectations of a rate cut at the next Fed meeting later this month. But then the wiseguys thought about it and decided to sell, sell, sell.

Witness negative revisions 77 percent of the time, with more coming.

It has been more than a month since Trump said on August 11th that his administration was “looking at” moving cannabis from Schedule I to Schedule III and would “make a determination over the next few weeks”.

Tsumura Co manufactures and sells Kampo medicine, a traditional form of medicine in Japan.